Recent Progress in Optical Sensors for Biomedical Diagnostics

In recent years, several types of optical sensors have been probed for their aptitude in healthcare biosensing, making their applications in biomedical diagnostics a rapidly evolving subject. Optical sensors show versatility amongst different receptor types and even permit the integration of different detection mechanisms. Such conjugated sensing platforms facilitate the exploitation of their neoteric synergistic characteristics for sensor fabrication. This paper covers nearly 250 research articles since 2016 representing the emerging interest in rapid, reproducible and ultrasensitive assays in clinical analysis. Therefore, we present an elaborate review of biomedical diagnostics with the help of optical sensors working on varied principles such as surface plasmon resonance, localised surface plasmon resonance, evanescent wave fluorescence, bioluminescence and several others. These sensors are capable of investigating toxins, proteins, pathogens, disease biomarkers and whole cells in varied sensing media ranging from water to buffer to more complex environments such as serum, blood or urine. Hence, the recent trends discussed in this review hold enormous potential for the widespread use of optical sensors in early-stage disease prediction and point-of-care testing devices.DFG, 428780268, Biomimetische Rezeptoren auf NanoMIP-Basis zur Virenerkennung und -entfernung mittels integrierter Ansätz

Grating-Coupled Surface Plasmon Resonance (GC-SPR) Optimization for Phase-Interrogation Biosensing in a Microfluidic Chamber.

Surface Plasmon Resonance (SPR)-based sensors have the advantage of being label-free, enzyme-free and real-time. However, their spreading in multidisciplinary research is still mostly limited to prism-coupled devices. Plasmonic gratings, combined with a simple and cost-effective instrumentation, have been poorly developed compared to prism-coupled system mainly due to their lower sensitivity. Here we describe the optimization and signal enhancement of a sensing platform based on phase-interrogation method, which entails the exploitation of a nanostructured sensor. This technique is particularly suitable for integration of the plasmonic sensor in a lab-on-a-chip platform and can be used in a microfluidic chamber to ease the sensing procedures and limit the injected volume. The careful optimization of most suitable experimental parameters by numerical simulations leads to a 30–50% enhancement of SPR response, opening new possibilities for applications in the biomedical research field while maintaining the ease and versatility of the configuration

Mid-infrared Gas Sensing Using Graphene Plasmons Tuned by Reversible Chemical Doping

Highly confined plasmon modes in nanostructured graphene can be used to detect tiny quantities of biological and gas molecules. In biosensing, a specific biomarker can be concentrated close to graphene, where the optical field is enhanced, by using an ad-hoc functional layer (e.g., antibodies). Inspired by this approach, in this paper we exploit the chemical and gas adsorption properties of an ultrathin polymer layer deposited on a nanostructured graphene surface to demonstrate a new gas sensing scheme. A proof-of-concept experiment using polyethylenimine (PEI) that is chemically reactive to CO2 molecules is presented. Upon CO2 adsorption, the sensor optical response changes because of PEI vibrational modes enhancement and shift in plasmon resonance, the latter related to polymer-induced doping of graphene. We show that the change in optical response is reversed during CO2 desorption. The demonstrated limit of detection (LOD) of 390 ppm corresponds to the lowest value detectable in ambient atmosphere, which can be lowered by operating in vacuum. By using specific adsorption polymers, the proposed sensing scheme can be easily extended to other relevant gases, for example, volatile organic compounds.Peer ReviewedPostprint (published version

Ultrasensitive detection of lipoarabinomannan with plasmonic grating biosensors in clinical samples of HIV negative patients with tuberculosis.

BACKGROUND:Timely diagnosis of tuberculosis disease is critical for positive patient outcomes, yet potentially millions go undiagnosed or unreported each year. Sputum is widely used as the testing input, but limited by its complexity, heterogeneity, and sourcing problems. Finding methods to interrogate noninvasive, non-sputum clinical specimens is indispensable to improving access to tuberculosis diagnosis and care. In this work, economical plasmonic gratings were used to analyze tuberculosis biomarker lipoarabinomannan (LAM) from clinical urine samples by single molecule fluorescence assay (FLISA) and compared with gold standard sputum GeneXpert MTB/ RIF, culture, and reference ELISA testing results. METHODS AND FINDINGS:In this study, twenty sputum and urine sample sets were selected retrospectively from a repository of HIV-negative patient samples collected before initiation of anti-tuberculosis therapy. GeneXpert MTB/RIF and culture testing of patient sputum confirmed the presence or absence of pulmonary tuberculosis while all patient urines were reference ELISA LAM-negative. Plasmonic gratings produced by low-cost soft lithography were bound with anti-LAM capture antibody, incubated with patient urine samples, and biotinylated detection antibody. Fluorescently labeled streptavidin revealed single molecule emission by epifluorescence microscope. Using a 1 fg/mL baseline for limit of detection, single molecule FLISA demonstrated good qualitative agreement with gold standard tests on 19 of 20 patients, including accurately predicting the gold-standard-negative patients, while one gold-standard-positive patient produced no observable LAM in urine. CONCLUSIONS:Single molecule FLISA by plasmonic grating demonstrated the ability to quantify tuberculosis LAM from complex urine samples of patients from a high endemic setting with negligible interference from the complex media itself. Moreover, agreement with patient diagnoses by gold standard testing suggests that single molecule FLISA could be used as a highly sensitive test to diagnose tuberculosis noninvasively

Plasmonic Metamaterials: Physical Background and Some Technological Applications

New technological frontiers appear every year, and few are as intriguing as the field of plasmonic metamaterials (PMMs). These uniquely designed materials use coherent electron oscillations to accomplish an astonishing array of tasks, and they present diverse opportunities in many scientific fields. This paper consists of an explanation of the scientific background of PMMs and some technological applications of these fascinating materials. The physics section addresses the foundational concepts necessary to understand the operation of PMMs, while the technology section addresses various applications, like precise biological and chemical sensors, cloaking devices for several frequency ranges, nanoscale photovoltaics, experimental optical computing components, and superlenses that can surpass the diffraction limit of conventional optics